2654-52-6

Basic information

• Product Name: 2,3-dimethylbenzothiazolium p-toluenesulphonate
• Synonyms: 2,3-dimethylbenzothiazolium p-toluenesulphonate;2,3-DIMETHYLBENZOTHIAZOLIUM P-TOLUENESULFONATE;2,3-Dimethyl-3-azoniabenzothiazole·tosylate;Benzothiazolium, 2,3-dimethyl-, 4-methylbenzenesulfonate (1:1);Benzothiazolium, 2,3-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1);Einecs 220-179-0;2,3-diMethylbenzothiazoliuM p-tolylsulphonate;2,3-Dimethylbenzothiazolium tosylate
• CAS NO: 2654-52-6
• Molecular Formula: C₇H₇O₃S*C₉H₁₀NS
• Molecular Weight: 335.44108
• EINECS: 220-179-0
• Mol File: 2654-52-6.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,3-dimethylbenzothiazolium p-toluenesulphonate(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-dimethylbenzothiazolium p-toluenesulphonate(2654-52-6)
• EPA Substance Registry System: 2,3-dimethylbenzothiazolium p-toluenesulphonate(2654-52-6)

Safety Data

• Hazardous Substances Data: 2654-52-6(Hazardous Substances Data)

Usage

General Description

2,3-Dimethylbenzothiazolium p-toluenesulphonate is a chemical compound with the molecular formula C16H16N2O3S2. It is commonly used as a catalyst in the polymerization of rubber and as a photoinitiator for the production of photopolymers. The compound is a bright yellow to orange powder with a melting point of 187-191°C. It is soluble in water, organic solvents, and glycol ethers, and is stable under normal conditions. 2,3-Dimethylbenzothiazolium p-toluenesulphonate is a highly reactive compound and should be handled with caution due to its potential to cause skin and eye irritation and respiratory issues if inhaled.

InChI:InChI=1/C9H10NS.C7H8O3S/c1-7-10(2)8-5-3-4-6-9(8)11-7;1-6-2-4-7(5-3-6)11(8,9)10/h3-6H,1-2H3;2-5H,1H3,(H,8,9,10)/q+1;/p-1

Upstream product

• 120-75-2 2-Methylbenzothiazole 
• 80-48-8 methyl p-toluene sulfonate 
• 20048-92-4 1-ethyl-2-methylquinolinium toluene-p-sulphonate 
• 38925-99-4 2,3-Dimethylbenzthiazoliummethosulfat 
• 23373-38-8 methyl toluenesulphonate 
• 137-07-5 2-amino-benzenethiol 

Downstream Products

• 121677-90-5 3-methyl-1,5-bis-(3-methyl-benzothiazol-2-yl)-pentamethinium ; toluene-4-sulfonate 
• 32901-38-5 5-methyl-4-[(3-methyl-3H-benzothiazol-2-yliden)-ethylidene]-2-phenyl-2,4-dihydro-pyrazol-3-one 
• 100834-60-4 2-benzyl-1,3-bis-(3-methyl-benzothiazol-2-yl)-trimethinium ; iodide 
• 103051-15-6 3-benzoyl-5-[(3-methyl-3H-benzothiazol-2-yliden)-ethylidene]-1-phenyl-2-thioxo-imidazolidin-4-one 
• 1788-56-3 3,3′-dimethyl-9-phenylthiacarbocyanine iodide 
• 22948-30-7 2-(3-carboxy-2-hydroxy-styryl)-3-methyl-benzothiazolium betaine 
• 112865-46-0 1-Ethyl-4-<3-methyl-2,3-dihydro-benzothiazolyliden-(2)-methyl>-chinolinium-iodid 
• 52378-94-6 2-Zimtsaeuremethylen-3-methylbenzothiazolin 
• 2783-70-2 2-phenacylbenzothiazole N-methyl enaminone 
• 2894-06-6 3-heptyl-5-[2-(3-methyl-3H-benzothiazol-2-ylidene)-ethylidene]-1-phenyl-2-thioxo-imidazolidin-4-one 
• 106290-87-3 Toluene-4-sulfonate2-((E)-2-{2-acetoxy-3-[2-[3-methyl-3H-benzothiazol-(2Z)-ylidene]-eth-(Z)-ylidene]-3H-inden-1-yl}-vinyl)-3-methyl-benzothiazol-3-ium; 
• 148528-54-5 Acetate₂-{(E)-2-[3-methoxy-4-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-phenyl]-vinyl}-3-methyl-benzothiazol-3-ium; 
• 108717-10-8 (2E,4Z)-4-(3-methylbenzo[d]thiazol-2(3H)-ylidene)-1-phenylbut-2-en-1-one 
• 802567-77-7 C₂₅H₂₁N₂S₂⁽¹⁺⁾ 

Relevant articles and documents

Benzodipyrrolenine-based biscyanine dyes: Synthesis, molecular structure and spectroscopic characterization

A novel method of synthesizing long-wavelength absorbing and emitting bis-trimethine dyes that consists of condensing benzodipyrrolenine dialdehyde with quaternized heterocyclic CH-acidic compounds was used to prepare a series of biscyanines. The new meth

New hexamethine indothia-cyanines: Synthesis and photophysical properties as well as both antitumor activity and imaging

Six new hexamethine indothia-cyanines were successfully synthesized by integrating a benzothiazole or naphthothiazole and indole unit using isophorone. These cyanines exhibited strong absorption and near-infrared fluorescence with a large stokes shift, and showed excellent stability. And they were tested as novel anticancer agents in vitro against human breast cancer cells (MCF-7), and indothia-cyanine D1 could efficiently reduce MCF-7 viability and exhibited no toxicity against normal human immortalized epidermal cells (Hacat). Cyanine D1 was further studied for its antitumor activity in mice. The in vivo result indicated that D1 could significantly inhibit the growth of breast tumors from tumor-bearing mice, and had no effect on the normal functions of the vital organs in vivo. In addition, D1 could stain MCF-7 cells and emitted bright red fluorescence, being a potential functional agent with both imaging and antitumor activity.

Synthesis and antileishmanial activity of fluorinated rhodacyanine analogues: The ‘fluorine-walk’ analysis

In a search for potent antileishmanial drug candidates, eighteen rhodacyanine analogues bearing fluorine or perfluoroalkyl substituents at various positions were synthesized. These compounds were tested for their inhibitory activities against Leishmania martiniquensis and L. orientalis. This ‘fluorine-walk’ analysis revealed that the introduction of fluorine atom at C-5, 6, 5′, or 6′ on the benzothiazole units led to significant enhancement of the activity, correlating with the less negative reduction potentials of the fluorinated analogues confirmed by the electrochemical study. On the other hand, [sbnd]CF3 and [sbnd]OCF3 groups were found to have detrimental effects, which agreed with the poor aqueous solubility predicted by the in silico ADMET analysis. In addition, some of the analogues including the difluorinated species showed exceptional potency against the promastigote and axenic amastigote stages (IC50 = 40–85 nM), with the activities surpassing both amphotericin B and miltefosine.